Farmacias Benavides SAB de CV

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: MXP3895X1106
MXN
26.00
1 (4.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 24.92%, it has a very expensive valuation with a 10.58 Price to Book Value

  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 4.00%, its profits have risen by 3.8% ; the PEG ratio of the company is 11.2
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

MXN 9,997 Million (Small Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

49.45%

stock-summary
Price to Book

11.58

Revenue and Profits:
Net Sales:
5,738 Million
(Quarterly Results - Mar 2026)
Net Profit:
104 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.04%
0%
13.04%
6 Months
30.0%
0%
30.0%
1 Year
37.57%
0%
37.57%
2 Years
192.13%
0%
192.13%
3 Years
188.25%
0%
188.25%
4 Years
85.71%
0%
85.71%
5 Years
52.94%
0%
52.94%

Farmacias Benavides SAB de CV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.26%
EBIT Growth (5y)
60.64%
EBIT to Interest (avg)
1.67
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
13.13
Tax Ratio
59.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
185.97%
ROE (avg)
42.53%

Valuation key factors

Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
10.58
EV to EBIT
9.59
EV to EBITDA
4.52
EV to Capital Employed
19.53
EV to Sales
0.48
PEG Ratio
11.21
Dividend Yield
NA
ROCE (Latest)
203.70%
ROE (Latest)
24.92%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 28.54% vs -3.19% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 14.63% vs 56.99% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,738.20",
          "val2": "4,464.00",
          "chgp": "28.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "582.10",
          "val2": "488.90",
          "chgp": "19.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "131.80",
          "val2": "122.50",
          "chgp": "7.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "104.20",
          "val2": "90.90",
          "chgp": "14.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.20%",
          "val2": "51.10%",
          "chgp": "0.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.27% vs 2.44% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 71.72% vs -53.77% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,458.50",
          "val2": "17,646.50",
          "chgp": "10.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,098.50",
          "val2": "1,908.60",
          "chgp": "9.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "469.00",
          "val2": "506.20",
          "chgp": "-7.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "224.10",
          "val2": "130.50",
          "chgp": "71.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.90%",
          "val2": "48.00%",
          "chgp": "0.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
5,738.20
4,464.00
28.54%
Operating Profit (PBDIT) excl Other Income
582.10
488.90
19.06%
Interest
131.80
122.50
7.59%
Exceptional Items
0.00
0.00
Consolidate Net Profit
104.20
90.90
14.63%
Operating Profit Margin (Excl OI)
51.20%
51.10%
0.01%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 28.54% vs -3.19% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 14.63% vs 56.99% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
19,458.50
17,646.50
10.27%
Operating Profit (PBDIT) excl Other Income
2,098.50
1,908.60
9.95%
Interest
469.00
506.20
-7.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
224.10
130.50
71.72%
Operating Profit Margin (Excl OI)
48.90%
48.00%
0.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 10.27% vs 2.44% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 71.72% vs -53.77% in Dec 2024

stock-summaryCompany CV
About Farmacias Benavides SAB de CV stock-summary
stock-summary
Farmacias Benavides SAB de CV
Retailing
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Company Coordinates stock-summary
Company Details
Avenida Fundadores No. 935 interior 301, Col. Valle del Mirador MONTERREY None : 64750
stock-summary
Tel: 52 81 8150770052 81 81507700
stock-summary
Registrar Details